Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses

Vaccines
Graham R Leggatt

Abstract

While T cells recognise the complex of peptide and major histocompatibility complex (MHC) at the cell surface, changes in the dose and/or structure of the peptide component can have profound effects on T cell activation and function. In addition, the repertoire of T cells capable of responding to any given peptide is variable, but broader than a single clone. Consequently, peptide parameters that affect the interaction between T cells and peptide/MHC have been shown to select particular T cell clones for expansion and this impacts on clearance of disease. T cells with high functional avidity are selected on low doses of peptide, while low avidity T cells are favoured in high peptide concentrations. Altering the structure of the peptide ligand can also influence the selection and function of peptide-specific T cell clones. In this review, we will explore the evidence that the choice of peptide dose or the structure of the peptide are critical parameters in an effective vaccine designed to activate T cells.

References

Jan 1, 1990·International Reviews of Immunology·A G LamontH M Grey
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A Alexander-MillerJ A Berzofsky
Aug 1, 1996·The Journal of Experimental Medicine·M A Alexander-MillerJ A Berzofsky
Jun 27, 1997·Science·M F BachmannR M Zinkernagel
Dec 22, 1999·European Journal of Immunology·G IezziA Lanzavecchia
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M DerbyJ Berzofsky
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A G CawthonM A Alexander-Miller
Oct 10, 2001·European Journal of Immunology·M A DerbyJ A Berzofsky
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·T N BullockV H Engelhard
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G Cawthon, Martha A Alexander-Miller
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sara E Hamilton, John T Harty
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Timothy N J BullockVictor H Engelhard
Feb 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·SangKon OhJay A Berzofsky
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ellen N KershRafi Ahmed
Dec 15, 1964·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·N A MITCHISON
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masha Fridkis-HareliEllis L Reinherz
Oct 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·SangKon OhJay A Berzofsky
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·James W HodgeJeffrey Schlom
Feb 25, 2006·Nature Reviews. Immunology·Lars HangartnerHans Hengartner
May 9, 2007·Immunology·Charles J Kroger, Martha A Alexander-Miller
Jun 23, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·James N KochenderferRonald E Gress
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles J Kroger, Martha A Alexander-Miller
Nov 1, 2007·Clinical Pharmacology and Therapeutics·H L Robinson
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles J KrogerMartha A Alexander-Miller
Aug 8, 2008·Journal of Clinical Gastroenterology·Marco SilanoMassimo De Vincenzi
Aug 21, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bérangère NeveuXavier Saulquin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.